KEVIN D. FREEMAN - Director at GALECTIN THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
GALT on Nasdaq
All Insider Reports
All Insider Reports

KEVIN D. FREEMAN - trading volume in the past year for GALECTIN THERAPEUTICS INC

Holdings reported by KEVIN D. FREEMAN for GALECTIN THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 80,000 $460,800 $5.76 23 Dec 2025 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC
Common Stock 55,269 $196,094 $3.55 23 Dec 2025 Direct
Common Stock 18,063 $104,042 $5.76 23 Dec 2025 IRA
Stock option (right to buy) 60,000 16 Jan 2026 Direct Common Stock

Transactions reported by KEVIN D. FREEMAN for GALECTIN THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.